December 15, 2024 18:29 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Kolkata woman strangled, beheaded and chopped into pieces for refusing brother-in-law's advances | Arvind Kejriwal, CM Atishi to contest Delhi polls from current constituencies | Atul Subhash suicide case: Wife Nikita, her mother and brother arrested | Pushpa 2 stampede: Allu Arjun walks out of jail, actor's lawyer slams delay in release | Donald Trump intends to end 'inconvenient' and 'very costly' Daylight Saving Time | Suchir Balaji: Indian-origin former OpenAI researcher found dead at US apartment | Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern'

Strides Consumer enters east India market with two uniquely formulated products

| @indiablooms | Jan 23, 2020, at 07:59 pm

Kolkata/IBNS: Bangalore based consumer healthcare company Strides Consumer Private Limited (SCPL) Thursday announced entry into the eastern market of India after successful expansion in southern regions.

With its entry, SCPL has launched two distinct products -Nixit, an oral Nicotine Replacement Therapy (NRT) and Jointflex, a topical analgesic cream for joint care.

At present, the NRT market is pegged at Rs 156 crore and projected to reach Rs 450 crore by 2023.

NIXIT has been priced at Rs. 49 for 2 mg gum and Rs 55 for 4 mg gum.

Jointflex, a topical analgesic cream, has been exclusively designed to address the joint pain segment and is a complete joint care product, claims the company.

Jointflex has been a preferred brand in the US for over 20 years now and also helping consumers in 15 other countries. In India, it comes as an ayurvedic formulation.

Speaking at the launch, Mr. Subodh Marwah, CEO, Strides Consumer Private Limited said, "Today, the consumer healthcare sector in India, which is valued at USD 3 billion and poised to witness a twofold growth by 2024. In such a scenario, it is imperative for any brand to deliver a proven solution in order to achieve high customer confidence. Our products NIXIT and JOINTFLEX are based on advanced formulations with extensive research to ensure we cater to the requirements of every consumer.”

Currently, SCPL is present in five southern states- Karnataka, Andhra Pradesh, Telangana, Tamil Nadu and Kerala and has a wide distribution network covering 50 plus towns.

It has opted in for similar distribution set up for eastern markets, including West Bengal, Madhya Pradesh, Chattisgarh,Odisha, Assam etc.

SCPL has two marquee investors India Life Sciences Fund with 74 per cent holdings and Strides Pharma Science Ltd (a listed company) with 26 per cent.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.